UCB U.S. News

UCB's Global Corporate Website

Welcome to UCB in the United States

Healthcare Professionals

Patients

Investors

05 UCB’s HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment

Read More Share:

Aug

01 Beyond Awareness: Uniting for a Brighter Future at the HS Summit

Read More Share:

Jul

31 Strength in Connection: The Role of Supportive Networks in Psoriatic Disease

Read More Share:

Jul

30 Building Talent, Shaping Futures: Why Interns Matter

Read More Share:

Jul

08 UCB extends its BIMZELX® “Get Yourself Back” direct-to-consumer campaign for the hidradenitis suppurativa community

Read More Share:

Jun

27 UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Read More Share:

Jun

20 UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

Read More Share:

Jun

17 Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.

Read More Share:

Jun

13 Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

Read More Share:

Jun

12 UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

Read More Share:

Categories

Archives

Aug

05

UCB’s HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment

Aug

01

Beyond Awareness: Uniting for a Brighter Future at the HS Summit

Jul

31

Strength in Connection: The Role of Supportive Networks in Psoriatic Disease

Jul

30

Building Talent, Shaping Futures: Why Interns Matter

Jul

08

UCB extends its BIMZELX® “Get Yourself Back” direct-to-consumer campaign for the hidradenitis suppurativa community

Jun

27

UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Jun

20

UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

Jun

17

Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.

Jun

13

Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

Jun

12

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

Choose Country

UCB in the U.S.

Innovation

Disease Areas

Sustainability

Newsroom

Contact

Categories

Archives

Aug

05

UCB’s HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment

Aug

01

Beyond Awareness: Uniting for a Brighter Future at the HS Summit

Jul

31

Strength in Connection: The Role of Supportive Networks in Psoriatic Disease

Jul

30

Building Talent, Shaping Futures: Why Interns Matter

Jul

08

UCB extends its BIMZELX® “Get Yourself Back” direct-to-consumer campaign for the hidradenitis suppurativa community

Jun

27

UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Jun

20

UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

Jun

17

Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.

Jun

13

Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

Jun

12

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

Choose Country

UCB in the U.S.

Innovation

Disease Areas

UCB Worldwide

Sustainability

Newsroom

Contact